{"status": "ok", "totalResults": 13, "articles": [{"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Rhiannon Hoyle, Feliz Solomon", "title": "Omicron Crept Into Australia After Strict Border Rules Eased...", "description": "Omicron Crept Into Australia After Strict Border Rules Eased...\r\n\n \n \n \n (Second column, 27th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:Rep. Pushes Wildly Different Covid Messages in Same-Day Hits on FOX, CNN...\r\nGerman doctor administered homemade vaccine to\u2026", "url": "https://www.wsj.com/articles/omicron-crept-into-australia-after-strict-border-rules-were-eased-11638263658", "urlToImage": "https://images.wsj.net/im-443012/social", "publishedAt": "2021-11-30T16:22:39Z", "content": "Health authorities around Europe and the Pacific Rim said dozens of cases of the Omicron variant of the coronavirus were identified in their countries and most carriers had entered before it was iden\u2026 [+290 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "The Wall Street Journal", "title": "COVID-19 variant omicron is unlikely to cause severe illness in vaccinated people, BioNTech founder says - Fox Business", "description": "<ol><li>COVID-19 variant omicron is unlikely to cause severe illness in vaccinated people, BioNTech founder says\u00a0\u00a0Fox Business\r\n</li><li>Pfizer could have a new vaccine against omicron Covid variant in less than 100 days: CEO Bourla\u00a0\u00a0CNBC Television\r\n</li><li\u2026", "url": "https://www.wsj.com/articles/omicron-unlikely-to-cause-severe-illness-in-vaccinated-people-biontech-founder-says-11638286176?mod=hp_lead_pos3", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/0/0/aworkergivesvaccine.jpg?ve=1&tl=1", "publishedAt": "2021-11-30T17:44:35Z", "content": "The omicron\r\n variant of the coronavirus could lead to more infections among vaccinated people but they will most likely remain protected from a severe course of illness, according to the inventor of\u2026 [+5342 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Kim Mackrael, Paul Vieira", "title": "U.S.-Canadian Border Rules Ease, Offering Boost to Local Business - The Wall Street Journal", "description": "Canadians taking short trips across the border no longer need molecular Covid-19 tests for their return trip", "url": "https://www.wsj.com/articles/u-s-canadian-border-rules-ease-offering-boost-to-local-business-11638286397", "urlToImage": "https://images.wsj.net/im-443182/social", "publishedAt": "2021-11-30T15:33:00Z", "content": "Beginning Tuesday, Canadians who have spent less than 72 hours in another country will no longer need a Covid-19 test to return to Canada, making it easier and cheaper for residents near the 5,500-mi\u2026 [+551 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Benjamin Katz, Jenny Strasburg", "title": "Omicron Variant Starts to Hit Travel, Business Flights and Events - The Wall Street Journal", "description": "Executives are paring back travel plans and events are getting canceled in the wake of the discovery of a new Covid-19 strain", "url": "https://www.wsj.com/articles/omicron-variant-starts-to-hit-travel-business-flights-and-events-11638290053", "urlToImage": "https://images.wsj.net/im-443248/social", "publishedAt": "2021-11-30T16:34:00Z", "content": "Airlines are warning of lower bookings, executives in Europe are tweaking business travel plans and a handful of organizations have canceled or downscaled events across the continent amid new governm\u2026 [+601 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Josh Mitchell, Paul Hannon", "title": "Covid-19 Variant Omicron Threatens U.S., Global Economies - The Wall Street Journal", "description": "<ol><li>Covid-19 Variant Omicron Threatens U.S., Global Economies\u00a0\u00a0The Wall Street Journal\r\n</li><li>Omicron Variant Could Boost Global Growth, According to Goldman Sachs Scenario\u00a0\u00a0Barron's\r\n</li><li>Hard for any central bank to withdraw stimulus amid omicron\u2026", "url": "https://www.wsj.com/articles/covid-19-variant-omicron-threatens-u-s-global-economies-11638268200", "urlToImage": "https://images.wsj.net/im-442802/social", "publishedAt": "2021-11-30T10:30:00Z", "content": "The global economy could suffer a modest blow from the Omicron variant of Covid-19, though the scale of damage will hinge on the potency of the strain itself, economists say.\r\nTourism spending will l\u2026 [+325 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Jon Emont, Nyimas Laula for The Wall Street Journal", "title": "Bali Was Slammed With Tourists Before Covid. Now It\u2019s Slammed Without. - The Wall Street Journal", "description": "Travel destinations that strained under crowds of visitors before the pandemic now confront the possibility they won\u2019t be back for years", "url": "https://www.wsj.com/articles/bali-covid-omicron-tourism-economy-travel-restrictions-11638229373", "urlToImage": "https://images.wsj.net/im-439366/social", "publishedAt": "2021-11-30T15:07:00Z", "content": "Two years ago, there were so many tourists on Bali that bumper-to-bumper traffic snaked through the Indonesian islands villages. Tides towed in waves of plastic garbage. A decadelong building binge t\u2026 [+389 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Wall Street Journal", "title": "Stock futures slide as omicron fears return - Fox Business", "description": "<ol><li>Stock futures slide as omicron fears return\u00a0\u00a0Fox Business\r\n</li><li>Bill Ackman says the Covid omicron variant could end up being bullish for markets\u00a0\u00a0CNBC\r\n</li><li>Hedge-fund investor who made $2.6 billion on pandemic trades says omicron could be bu\u2026", "url": "https://www.wsj.com/articles/global-stock-markets-dow-update-11-30-2021-11638261250?mod=markets_lead_pos3", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2018/12/0/0/nyse-trader140418-b.jpg?ve=1&tl=1", "publishedAt": "2021-11-30T08:52:18Z", "content": "U.S. stock futures broadly declined, extending a period of volatile trading since the detection of the Omicron variant of Covid-19.\r\nFutures on the S&amp;P 500 were down 0.9% and futures tied to the \u2026 [+1716 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Will Horner", "title": "Stock Futures, Oil Drop on Omicron Vaccine Concerns - The Wall Street Journal", "description": "<ol><li>Stock Futures, Oil Drop on Omicron Vaccine Concerns\u00a0\u00a0The Wall Street Journal\r\n</li><li>Moderna CEO: Could take weeks for more clarity on omicron Covid variant\u00a0\u00a0CNBC Television\r\n</li><li>Dow Futures Down 1%; Worries Over Omicron Variant Rise By Investi\u2026", "url": "https://www.wsj.com/articles/global-stock-markets-dow-update-11-30-2021-11638261250", "urlToImage": "https://images.wsj.net/im-443009/social", "publishedAt": "2021-11-30T11:59:00Z", "content": "U.S. stock indexes fell at the opening and investors sheltered in government bonds after drugmakers raised concerns that Covid-19 vaccines wont work as well against the new Omicron strain.\r\nThe S&amp\u2026 [+251 chars]"}, {"source": {"id": "the-verge", "name": "The Verge"}, "author": "Kim Lyons", "title": "Amazon faces new pressure over COVID protections in warehouses", "description": "New York\u2019s Attorney General Letitia James filed suit against Amazon in state Supreme Court on Tuesday, alleging the company continues to fail to provide health and safety protections for its warehouse workers.", "url": "https://www.theverge.com/2021/11/30/22810754/amazon-new-york-ag-reinstate-fired-worker-health-safety-covid", "urlToImage": "https://cdn.vox-cdn.com/thumbor/YjbfHZiWlA87Q4ArcpTv7B1ibIM=/0x481:6720x3999/fit-in/1200x630/cdn.vox-cdn.com/uploads/chorus_asset/file/23054027/1211474779.jpg", "publishedAt": "2021-11-30T23:01:12Z", "content": "AG Letitia James filed suit in state Supreme Court on Tuesday\r\nAmazon workers protested outside a warehouse last year\r\nSpencer Platt / Getty Images\r\nAmazon is facing new questions over failed COVID p\u2026 [+3513 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Jared S. Hopkins And Betsy Mckay", "title": "Merck\u2019s Covid-19 Pill to Be Reviewed by FDA Advisers", "description": "Oral antiviral pill was recently found to be 30% effective at reducing risk of hospitalization and death in high-risk people", "url": "https://www.wsj.com/articles/covid-19-vaccine-pill-merck-11638225869", "urlToImage": "https://images.wsj.net/im-443191/social", "publishedAt": "2021-11-30T10:31:47Z", "content": "An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck &amp; Co. and partner Ridgeba\u2026 [+188 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Joseph Walker", "title": "Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates", "description": "Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant", "url": "https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003", "urlToImage": "https://images.wsj.net/im-442775/social", "publishedAt": "2021-11-30T11:04:34Z", "content": "Preliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an impor\u2026 [+382 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Stephanie Armour And Jared S. Hopkins", "title": "FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds", "description": "The agency could clear use of the extra doses as soon as next week as concerns rise over Omicron variant", "url": "https://www.wsj.com/articles/fda-moving-to-authorize-pfizer-biontech-booster-for-16-17-year-olds-11638233782", "urlToImage": "https://images.wsj.net/im-442905/social", "publishedAt": "2021-11-30T00:59:46Z", "content": "The Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. and BioNTech SE for use in 16- and 17-year olds as soon as next week as concerns rise over a new, possibly more tra\u2026 [+315 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Bojan Pancevski", "title": "Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Founder Says", "description": "Variant could lead to more infections but vaccinated people likely remain protected from severe disease, Ugur Sahin says", "url": "https://www.wsj.com/articles/omicron-unlikely-to-cause-severe-illness-in-vaccinated-people-biontech-founder-says-11638286176", "urlToImage": "https://images.wsj.net/im-443086/social", "publishedAt": "2021-11-30T15:29:00Z", "content": "BERLINThe Omicron variant of the coronavirus could lead to more infections among vaccinated people but they will most likely remain protected from a severe course of illness, according to the invento\u2026 [+264 chars]"}]}